Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Spanish group synthesizes novel anti-inflammatory agents

July 30, 2012

Reata Pharmaceuticals presents new inhibitors of NO production

July 17, 2012

RNAi screen identifies targets for diseases involving protein misfolding

Jan. 13, 2012

Celtaxsys obtains anti-inflammatory drug from Estrellita Pharmaceuticals

Jan. 12, 2012

Novel anti-inflammatory agents discovered in U.K.

Jan. 11, 2012

Novel inhibitors of cytochrome P450 enzymes synthesized by Angion Biomedica

Jan. 5, 2012

Lilly withdraws Xigris worldwide following PROWESS-SHOCK study

Oct. 26, 2011

Karolinska Institutet presents novel series of selenium-containing antioxidants

May 6, 2011

Phase I trial to assess MLN-9708 in relapsed/refractory light chain amyloidosis under way

March 28, 2011

Roskamp Institute obtains IRB approval for study of RCP-006 in humans

March 4, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 31, 2025
Novo Nordisk licenses Lexicon’s preclinical obesity drug in $1B deal
BioWorld Science
As companies continually search for next-generation obesity prospects, one of the leaders in the disease space, Novo Nordisk A/S, has obtained an exclusive...
Corcept looks to NDA following strong phase III ovarian cancer data
BioWorld
Relacorilant, a cortisol modulator from Corcept Therapeutics Inc., produced new and strong phase III results in treating platinum-resistant ovarian cancer. The...
Otsuka submits first BLA to FDA for sibeprenlimab in IgAN
BioWorld
Otsuka Pharmaceutical Development & Commercialization Inc. filed its BLA with the U.S. FDA for sibeprenlimab to treat immunoglobulin A nephropathy (IgAN). The...